Prostate International

Papers
(The TQCC of Prostate International is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification50
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization33
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey20
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer19
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy18
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer18
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study17
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study16
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis16
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship16
Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects16
Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum15
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study14
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign 14
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre13
The prevalence of dyslipidemia in patients with prostate cancer12
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis12
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data12
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients12
Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia11
Transurethral water vapor therapy (Rezūm) for acute urinary retention with obstructive uropathy: a prospective cohort study with one-year follow-up11
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures11
The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension11
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer10
Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience10
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia10
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer10
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg10
Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg10
Clinical implication of peri-seminal vesicle soft-tissue invasion in patients with pT3b prostate cancer10
Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study9
Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study9
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer9
Oncologic outcomes of salvage radiotherapy and lymphadenectomy for positron emission tomography–positive lymph nodes in biochemical recurrence: A systematic review to inform treatment decisions9
Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings8
High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group8
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation8
Irreversible electroporation for prostate cancer using PSMA PET-CT8
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results8
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)8
Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis8
Utilization of prostate-specific membrane antigen positron emission tomography in Australia following government subsidization: Trends in primary staging and biochemical recurrence7
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review7
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system7
Prostate diseases and microbiome in the prostate, gut, and urine7
Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis7
A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density7
0.042296886444092